Literature DB >> 16718797

Efficacy of one-day quadruple therapy for H pylori infection in Chinese patients.

Xiao-Hui Huo1, Jian-Kun Chu, Xiu-Fen Yang, Jing Wang, Li-Jing Zhang, Jin-Cheng Ma, Jun Yu.   

Abstract

AIM: To compare the efficacies of one-day quadruple therapy and seven-day triple therapy in Chinese patients.
METHODS: Sixty consecutive patients with nonulcer dyspepsia and confirmed H pylori infection were randomized to receive either omeprazole 40 mg, amoxycillin 1 g, and furazolidone 100 mg, all twice a day for 7 d or omeprazole 20 mg (at breakfast and dinner), amoxicillin 1 g, furazolidone 200 mg, and colloidal bismuth subcitrate 220 mg four times for only one day. H pylori status was determined before and at least 5 weeks after therapy by endoscopy with antral and corpus biopsies for rapid urease test and histology.
RESULTS: H pylori eradication was successful in 66.67% (20/30) patients in the 7-d group and in 36.67% (11/30) patients in the 1-d group (P = 0.037). Side effects were induced by the treatment in 13.3% (4/30) patients of each group, but these were all self-limiting, short-lasting, and did not require any specific treatment.
CONCLUSION: The one-day quadruple therapy is less effective than the one-week regimen in curing H pylori infection in Chinese patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16718797      PMCID: PMC4124391          DOI: 10.3748/wjg.v12.i19.3105

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  15 in total

1.  Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.

Authors:  J J Sung; S C Chung; T K Ling; M Y Yung; V K Leung; E K Ng; M K Li; A F Cheng; A K Li
Journal:  N Engl J Med       Date:  1995-01-19       Impact factor: 91.245

2.  One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection.

Authors:  Luis F Lara; Gerardo Cisneros; Michael Gurney; Michael Van Ness; David Jarjoura; Betty Moauro; Ann Polen; Gregory Rutecki; Frederick Whittier
Journal:  Arch Intern Med       Date:  2003-09-22

3.  One-day therapy for treatment of Helicobacter pylori infection.

Authors:  A Tucci; R Corinaldesi; V Stanghellini; G F Paparo; S Gasperoni; G Biasco; O Varoli; M Ricci-Maccarini; L Barbara
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

4.  Impact of metronidazole resistance on the eradication of Helicobacter pylori.

Authors:  L A Noach; W L Langenberg; M A Bertola; J Dankert; G N Tytgat
Journal:  Scand J Infect Dis       Date:  1994

5.  Disappearance of gastritis after eradication of Helicobacter pylori. A morphometric study.

Authors:  J Valle; K Seppälä; P Sipponen; T Kosunen
Journal:  Scand J Gastroenterol       Date:  1991-10       Impact factor: 2.423

6.  Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance.

Authors:  G D Bell; K Powell; S M Burridge; A Pallecaros; P H Jones; P W Gant; G Harrison; J E Trowell
Journal:  Aliment Pharmacol Ther       Date:  1992-08       Impact factor: 8.171

7.  Factors influencing the eradication of Helicobacter pylori with triple therapy.

Authors:  D Y Graham; G M Lew; H M Malaty; D G Evans; D J Evans; P D Klein; L C Alpert; R M Genta
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682

8.  Factors associated with treatment failure of Helicobacter pylori infection in a developing country.

Authors:  Dulciene Maria Magalhães Queiroz; Renato Dani; Luciana Diniz Silva; Adriana Santos; Liano Sia Moreira; Gifone Aguiar Rocha; Paulo Renato Valle Corrêa; Luiz Fernando Abrahão Reis; Ana Margarida Ferreira Nogueira; Mônica Maria Demas Alvares Cabral; Ana Maria Brás Esteves; Jansen Tanure
Journal:  J Clin Gastroenterol       Date:  2002-10       Impact factor: 3.062

9.  Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer.

Authors:  E Hentschel; G Brandstätter; B Dragosics; A M Hirschl; H Nemec; K Schütze; M Taufer; H Wurzer
Journal:  N Engl J Med       Date:  1993-02-04       Impact factor: 91.245

10.  Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates.

Authors:  Anita Paula Ortiz Godoy; Marcelo Lima Ribeiro; Yune Helena Borges Benvengo; Lea Vitiello; Maira de Carvalho Bueno Miranda; Sergio Mendonça; José Pedrazzoli
Journal:  BMC Gastroenterol       Date:  2003-08-11       Impact factor: 3.067

View more
  3 in total

Review 1.  Is short-term therapy really sufficient to eradicate Helicobacter pylori infection?

Authors:  Ning Zhou; Wei-xing Chen; Wei Zhang; Lan Li; Xi Jin; You-ming Li
Journal:  J Zhejiang Univ Sci B       Date:  2010-09       Impact factor: 3.066

Review 2.  Bismuth-containing quadruple therapy for Helicobacter pylori: lessons from China.

Authors:  Hong Lu; Wei Zhang; David Y Graham
Journal:  Eur J Gastroenterol Hepatol       Date:  2013-10       Impact factor: 2.566

Review 3.  Furazolidone-based therapies for Helicobacter pylori infection: a pooled-data analysis.

Authors:  Angelo Zullo; Enzo Ierardi; Cesare Hassan; Vincenzo De Francesco
Journal:  Saudi J Gastroenterol       Date:  2012 Jan-Feb       Impact factor: 2.485

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.